The expression of miR-146a is altered in various cancers (88, 89) and reportedly targets IRAK1 and TRAF6, leading to the inactivation of the inflammatory, tumorigenic NF-kB signaling pathway (90, 91), apoptosis stimulation, and cancer cell proliferation reduction (92). This evidence concerns the gene NFKB1 and cancer.